载脂蛋白A4(APOA4)重组蛋白

Recombinant Apolipoprotein A4 (APOA4)

ApoA-IV; ApoAIV; Apo-A4

  • 载脂蛋白A4(APOA4)重组蛋白 产品包装(模拟)
  • 载脂蛋白A4(APOA4)重组蛋白 产品包装(模拟)
  • RPB967Mu01.jpg SDS-PAGE图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

PBS或其它。

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPB967Mu02 载脂蛋白A4(APOA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB967Mu01 载脂蛋白A4(APOA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB967Mu01 载脂蛋白A4(APOA4)多克隆抗体 WB; IHC; ICC; IP.
PAB967Mu02 载脂蛋白A4(APOA4)多克隆抗体 WB; IHC; ICC; IP.
LAB967Mu81 载脂蛋白A4(APOA4)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAB967Mu71 载脂蛋白A4(APOA4)多克隆抗体(生物素标记) WB; IHC; ICC.
SEB967Mu 载脂蛋白A4(APOA4)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
HEB967Mu 载脂蛋白A4(APOA4)检测试剂盒(酶联免疫吸附试验法,高敏型) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB967Mu 载脂蛋白A4(APOA4)等多因子检测试剂盒(流式荧光发光法) FLIA Assay for Antigen Detection.
KSB967Mu01 载脂蛋白A4(APOA4)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Biochimica et Biophysica Acta Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties [PubMed: 23328279 ]
Exp Ther Med. Differential plasma proteome analysis in patients with high?altitude pulmonary edema at the acute and recovery phases [Pubmed:24940404]
EuPA Open Proteomics Human maternal plasma proteomic changes with parturition [Sciencedirect:S2212968514000506]
BJOG Development of concise audit standards for unplanned return to theate following gynaecological surgery at Gloucestershire Royal Hospital [Doi: 10.1111]
Diagnostics Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J [Pubmed: 32585848]
VETERINARY PATHOLOGY Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats [Pubmed: 32880234]
Cancer Cell Int Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer [33602229]
留言咨询